Compugen Ltd. , a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Compugen stock last closed at $1.39, down 5.44% from the previous day, and has decreased 26.46% in one year. It has overperformed other stocks in the Biotechnology industry by 0.51 percentage points. Compugen stock is currently +23.01% from its 52-week low of $1.13, and -47.74% from its 52-week high of $2.66.
As of Apr 21, 2025, there are 89.54M shares of CGEN outstanding. The market capitalization of CGEN is $124.46M. In the past 24 hours, 200,624 CGEN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy CGEN shares.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to buy CGEN today.
Now that you have created your account on the best stock trading app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new investment account.
Once you have identified the best place to buy Compugen stock, it's absolutely critical to evaluate their stock before you invest, so you actually understand the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CGEN's fair value.
Using relative valuations metrics:
You can do additional valuation research on CGEN's stock here.
You can dig deeper into what analysts are forecasting on the Compugen stock forecast page.
Last year, CGEN revenue was $27.86M. Over the last 4 year, CGEN's revenue has increased by 93.2% per year. This was faster than the Biotechnology industry average of 44.31%.
Dive into CGEN's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at CGEN have not bought or sold any shares.
Learn more about who owns CGEN shares here.
No, Compugen doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two main types of orders:
Hit the Open button and eToro will execute your order.
If you need more info about buying stocks on eToro, watch the how to video below:
Now that you own some shares in CGEN, you'll want to stay up-to-date on your investment.
Start a watchlist to monitor your CGEN stock.
To reiterate, here are the 6 steps you need to take to buy Compugen stock right now:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your investment in Compugen, create a watchlist today.